Calcifediol in the Treatment of COVID 19

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Patients hospitalized with COVID-19 treated with calcifediol during the first outbreaks of the pandemic (until the first vaccinations) are compared with the aim of determining the therapeutic, clinical, functional, and biochemical variables that modify the response (admission to ICU or death) to calcifediol during hospitalization for COVID 19
Epistemonikos ID: f3d03d958f4f23a60a2cf20c45740ae299c74f33
First added on: Apr 20, 2023